Citation Impact
Citing Papers
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Epigenetics in liver disease: from biology to therapeutics
2016
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
2017
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage
2022 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
2011
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
2014
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
2015
From NASH to HCC: current concepts and future challenges
2019
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Molecular and histological correlations in liver cancer
2019
Therapeutic modulation of Notch signalling — are we there yet?
2014
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Advances in molecular classification and precision oncology in hepatocellular carcinoma
2020
Mechanisms of hepatic stellate cell activation
2017 Standout
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
2012
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
2017
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
2016
Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles
2020
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
2014
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results
2017
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Cancer stem cells revisited
2017 Standout
Tumor stroma reaction‐related gene signature predicts clinical outcome in human hepatocellular carcinoma
2011
Survival analysis tools in genomics research
2014
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
2016
Pyroptosis: mechanisms and diseases
2021 Standout
Liver cancer: Approaching a personalized care
2015
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Mechanisms of HBV-induced hepatocellular carcinoma
2016
The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
2014
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
2020 StandoutNobel
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Cancer gene discovery in hepatocellular carcinoma
2010
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
2019
Ulcerative colitis
2020 Standout
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
2013
The molecular landscape of head and neck cancer
2018 Standout
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2022
Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling
2018 StandoutNobel
MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing
2013
Molecular therapies and precision medicine for hepatocellular carcinoma
2018
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
2021
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America
2016
Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma
2016
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
2015
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
2013
Hepatocellular carcinoma
2022 Standout
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
2013
Histone deacetylases and cancer
2012
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
2020 StandoutNobel
Functional and genetic deconstruction of the cellular origin in liver cancer
2015
Targeted Therapies for Hepatocellular Carcinoma
2011
Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
2014
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential
2015
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
2012
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Gene expression profiles in hepatocellular carcinoma: not yet there
2004
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
2014
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
2012
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
2013
Insulin-Like Growth Factor (IGF) System in Liver Diseases
2018
Induction of hepatocellular carcinoma by in vivo gene targeting
2012
The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma
2020
Targeting DNA‐Dependent Protein Kinase for Cancer Therapy
2017
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
A method for characterizing Cas9 variants via a one-million target sequence library of self-targeting sgRNAs
2021
Epigenetic control of intestinal barrier function and inflammation in zebrafish
2015
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Determinants of IBD Heritability: Genes, Bugs, and More
2018
Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis
2015
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Simultaneous precise editing of multiple genes in human cells
2019 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cellular Homeostasis and Repair in the Mammalian Liver
2015
Works of Clara Alsinet being referenced
DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
2014
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
2012
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
2015
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
2016
Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
2012
Predicting the mutations generated by repair of Cas9-induced double-strand breaks
2018
UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
2014
Gene Signatures in the Management of Hepatocellular Carcinoma
2012
Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
2012
VEGF Signaling in Cancer Treatment
2014
Molecular Pathogenesis of Hepatocellular Carcinoma
2011
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
2010
Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR
2012
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
2011
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
2011
New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers
2010